SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Nelkarmi Approved in US for Previously Treated Advanced ALK-Positive Lung Cancer

The approval was based on the phase I/II ALKOVE-1 trial, which demonstrated clinically meaningful and durable response.

GSK

Related stories